(NASDAQ: ANNX) Annexon's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 14.28%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34%.
Annexon's earnings in 2026 is -$198,333,000.On average, 12 Wall Street analysts forecast ANNX's earnings for 2026 to be -$189,582,201, with the lowest ANNX earnings forecast at -$197,495,795, and the highest ANNX earnings forecast at -$170,314,318. On average, 12 Wall Street analysts forecast ANNX's earnings for 2027 to be -$142,985,383, with the lowest ANNX earnings forecast at -$181,439,227, and the highest ANNX earnings forecast at -$68,813,866.
In 2028, ANNX is forecast to generate $15,597,810 in earnings, with the lowest earnings forecast at -$99,550,726 and the highest earnings forecast at $220,204,371.